The pathological diagnosis was invasive ductal carcinoma, nuclear grade 1, ER+ (J score 3b), PgR+ (J score 3a), HER2- (score 1+), with a Ki67-labeling index of less than 5%. This evidence concerns the gene ERBB2 and invasive ductal breast carcinoma.